EP Patent

EP1954257A4 — METHODS OF TREATING CENTRAL NERVOUS SYSTEM DISORDERS WITH LOW ESCITALOPRAM AND BUPROPION DOSE COMBINATION

Assigned to H Lundbeck AS · Expires 2009-05-20 · 17y expired

What this patent protects

Patent listed against bupropion-hydrobromide.

Drugs covered by this patent

bupropion-hydrobromide (BUPROPION HYDROBROMIDE)

Patent Metadata

Patent number: EP1954257A4
Jurisdiction: EP
Classification: —
Expires: 2009-05-20
Drug substance claim: No
Drug product claim: No
Assignee: H Lundbeck AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.